TriviumVet sign worldwide exclusive veterinary license agreement for new molecule Tavocept

“Trivium Vet sign worldwide exclusivity license agreement with Bionumerik

Under the worldwide license agreement TriviumVet are granted exclusive rights to the Tavocept drug compound for all veterinary applications. Research is ongoing for multiple applications of the product in both the canine and feline species.”

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest